cilengitide
Term · Oncology and biomedicine · MLC-T-ONC-001766
A substance that is being studied as an anticancer and antiangiogenesis drug. Also called EMD 121974.
A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis.
| Identifier | MLC-T-ONC-001766 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | EMD 121974 |
| Synonyms | EMD 121974 |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-001766",
"term": "cilengitide",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that is being studied as an anticancer and antiangiogenesis drug. Also called EMD 121974.",
"A cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(v)beta(3) and alpha(v)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis."
],
"abbreviation": "EMD 121974",
"synonyms": [
"EMD 121974"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cilengitide/"
}
Record 4,851 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.